Q2 results, order win drive Symbiotec Pharma 20% higher to new high
Symbiotec Pharmalab's stock got listed on September 1 this year and has rallied 54 per cent from the IPO price of ₹988 apiece.
Read the full story at Business Standard →
More in Business
- Penny stock under ₹10 hits 5% upper circuit on Dhanteras 2026 date; finds no seller for third straight session
- 13% single-day gain! This Tata Group stock skyrockets on Dhanteras - Do you own? Check annual return, technical targets
- Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highs
- Bosch slips 4% from day's high; announces 1:5 stock split, 3:1 bonus issue
- TTK Prestige share price climbs 14% after Q2 profit rise 65% to ₹104 crore
- Gold ETF Dhanteras 2026: Tata Gold Exchange Traded Fund — 60% returns within 3 years of launch! Should you buy?